Company · CIK 0001721484 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Longeveron Inc. · LGVN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 AForm 4 → | Aug 21, 6:00 pm EDT | Paul T LehrGeneral Counsel, Secretary | 286,000 | — | — | 861,423 | — | |
| Aug 19, 2026 AForm 4 → | Aug 21, 6:00 pm EDT | Roger Joseph HajjarDirector | 36,000 | — | — | 69,000 | — | |
| Aug 19, 2026 AForm 4 → | Aug 21, 6:00 pm EDT | Rock SofferDirector | 36,000 | — | — | 262,034 | — | |
| Aug 19, 2026 AForm 4 → | Aug 21, 6:00 pm EDT | George A. Paletta Jr.Director | 36,000 | — | — | 70,000 | — | |
| Aug 19, 2026 AForm 4 → | Aug 21, 6:00 pm EDT | Ursula UngaroDirector | 36,000 | — | — | 77,000 | — | |
| Aug 19, 2026 AForm 4 → | Aug 21, 6:00 pm EDT | Leah Rush CannDirector | 36,000 | — | — | 36,000 | — | |
| Aug 19, 2026 AForm 4 → | Aug 21, 6:00 pm EDT | Arjun JJ DesaiDirector | 36,000 | — | — | 36,000 | — | |
| Aug 19, 2026 AForm 4 → | Aug 21, 6:00 pm EDT | Devin BlassCTO & SVP of CMC | 286,000 | — | — | 711,735 | — | |
| Aug 19, 2026 AForm 4 → | Aug 21, 6:00 pm EDT | Nataliya AgafonovaChief Medical Officer | 286,000 | — | — | 716,914 | — | |
| Aug 19, 2026 AForm 4 → | Aug 21, 6:00 pm EDT | Deborah AscheimDirector | 36,000 | — | — | 36,000 | — | |
| Aug 19, 2026 AForm 4 → | Aug 21, 6:00 pm EDT | Joshua HareChief Scientific Officer, Director, 10% Owner | 286,000 | — | — | 1,607,796 | — | |
| Aug 17, 2026 AForm 4 → | Aug 25, 6:05 pm EDT | Nirav S. JhaveriChief Financial Officer | 300,000 | — | — | 300,000 | — | late |
| Jul 6, 2026 AForm 4 → | Jul 8, 6:00 pm EDT | Joshua HareChief Scientific Officer, Director, 10% Owner | 600,000 | — | — | 1,321,796 | — | |
| Jul 1, 2026 FForm 4 → | Jul 6, 8:55 pm EDT | Stephen H WillardChief Executive Officer | 18,046 | $0.7291 | $13,157 | 771,681 | — | |
| Jul 1, 2026 FForm 4 → | Jul 6, 8:55 pm EDT | Lisa LocklearChief Financial Officer | 22,505 | $0.7291 | $16,408 | 443,181 | — | |
| Jul 1, 2026 FForm 4 → | Jul 6, 8:54 pm EDT | Nataliya AgafonovaChief Medical Officer | 22,505 | $0.7291 | $16,408 | 430,914 | — | |
| Jul 1, 2026 FForm 4 → | Jul 6, 8:54 pm EDT | Devin BlassCTO & SVP of CMC | 15,808 | $0.7291 | $11,526 | 425,735 | — | |
| Jul 1, 2026 FForm 4 → | Jul 6, 8:54 pm EDT | Paul T LehrGeneral Counsel, Secretary | 13,143 | $0.7291 | $9,583 | 575,423 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 AForm 4 → | Jul 8, 6:00 pm EDT | Joshua HareChief Scientific Officer, Director, 10% Owner | 400,000 | — | — | 400,000 | — |